Blood potassium decreased and Upper respiratory tract infection

Summary:

Upper respiratory tract infection is found among people with Blood potassium decreased, especially for people who are female, 60+ old.

The study analyzes which people have Upper respiratory tract infection with Blood potassium decreased. It is created by eHealthMe based on reports of 48 people who have Blood potassium decreased from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Blood potassium decreased?

Blood potassium decreased is found to be associated with 1,632 drugs and 1,722 conditions by eHealthMe. Check the latest studies of Blood potassium decreased.

What is Upper respiratory tract infection?

Upper respiratory tract infection is found to be associated with 1,900 drugs and 1,769 conditions by eHealthMe. Check the latest studies of Upper respiratory tract infection.



On Jul, 17, 2026

48 people who have Blood Potassium Decreased and Upper Respiratory Tract Infection are studied.

Would you have Upper respiratory tract infection when you have Blood potassium decreased?

Gender of people who have Blood Potassium Decreased and experienced Upper Respiratory Tract Infection *:

  • female: 77.08 %
  • male: 22.92 %

Age of people who have Blood Potassium Decreased and experienced Upper Respiratory Tract Infection *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 2.13 %
  • 40-49: 17.02 %
  • 50-59: 21.28 %
  • 60+: 59.57 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 33 people, 68.75%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 27 people, 56.25%
  3. Nausea (feeling of having an urge to vomit): 19 people, 39.58%
  4. Diarrhea: 18 people, 37.50%
  5. Indigestion: 17 people, 35.42%
  6. Arrhythmias (irregular heartbeat): 17 people, 35.42%
  7. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 16 people, 33.33%
  8. Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up): 16 people, 33.33%
  9. Febrile Neutropenia (fever with reduced white blood cells): 16 people, 33.33%
  10. Rashes (redness): 16 people, 33.33%

Common drugs taken by these people *:

  1. Potassium: 22 people, 45.83%
  2. Pantoprazole: 17 people, 35.42%
  3. Abraxane: 16 people, 33.33%
  4. Nexium: 8 people, 16.67%
  5. Claritin: 7 people, 14.58%
  6. Folic Acid: 7 people, 14.58%
  7. Zoloft: 7 people, 14.58%
  8. Vitamin D3: 6 people, 12.50%
  9. Prilosec: 6 people, 12.50%
  10. Prednisone: 6 people, 12.50%

Common symptoms for these people *:

  1. Diarrhea: 27 people, 56.25%
  2. Fatigue (feeling of tiredness): 25 people, 52.08%
  3. Presyncope: 16 people, 33.33%
  4. Skin Ulcer: 16 people, 33.33%
  5. Fever: 13 people, 27.08%
  6. Back Pain: 12 people, 25.00%
  7. Abdominal Pain: 12 people, 25.00%
  8. Cough: 11 people, 22.92%
  9. Pneumonia: 10 people, 20.83%
  10. Anaemia (lack of blood): 10 people, 20.83%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Upper respiratory tract infection?

- Check whether Upper respiratory tract infection is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Upper respiratory tract infection:

All the conditions that are associated with Upper respiratory tract infection:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Upper respiratory tract infection and Blood potassium decreased, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe:

No recent updates.